Predicate |
Object |
contentType |
Journal Article |
endingPage |
e15 |
issn |
1718-7729 |
issueIdentifier |
1 |
pageRange |
e9-e15 |
publicationName |
Current oncology (Toronto, Ont.) |
startingPage |
e9 |
bibliographicCitation |
Al-Saleh K, Quinton C, Ellis PM. Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis. Curr Oncol. 2012 Feb;19(1):e9–e15. PMID: 22328848; PMCID: PMC3267597. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1695baf44e8922b28b6f0b26005bc110 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94940af120a7574bea7724a7d66e664f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2069185d7612cef29f1b184629abe84 |
date |
2012-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/22328848 https://doi.org/10.3747/co.19.891 https://pubmed.ncbi.nlm.nih.gov/PMC3267597 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33334 https://portal.issn.org/resource/ISSN/1718-7729 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Role of Pemetrexed in Sdvanced Non-Small-Cell Lung Cancer: Meta-Analysis of Randomized Controlled Trials, with Histology Subgroup Analysis |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 |